Literature DB >> 1346620

T cell surface molecules regulating noncognate B lymphocyte activation. Role of CD2 and LFA-1.

J Sen1, P Bossu, S J Burakoff, A K Abbas.   

Abstract

A central event in humoral responses is the Ag-mediated interaction of Th cells and B cells. This interaction leads to the activation of both cell types and results in cytokine secretion by the T cells and proliferation and secretion of Ig by the B cells. The proliferative and differentiative responses of B cells are dependent on contact-mediated signals and cytokines provided by the activated Th cells. Although the role of cytokines in B cell activation and differentiation is understood, the nature of the signals delivered by the activated Th cells and the molecules involved in this process are not known. In this study we have examined Ag-mediated "cognate" T-B cell interactions as well as B cell activation induced by contact with preactivated and fixed Th lymphocytes. Our results indicate that both the T cell surface molecules lymphocyte function associated Ag-1 and CD2 are important in the activation of T cells by Ag presented by B lymphocytes. This indicates that B cells have similar characteristics as other APC. However, once the T cells are activated, contact-mediated stimulation of resting B lymphocytes (the noncognate phase) is dependent on CD2 but not lymphocyte function associated Ag-1. Two lines of evidence indicate this; first, it is inhibited by blocking of CD2 on the T cells and, second, such stimulation is not efficiently mediated by a CD2- Th cell line. Thus, CD2 plays an obligatory role at several discrete stages of T cell-mediated activation of resting B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346620

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans.

Authors:  L M Allende; M Hernández; A Corell; M A García-Pérez; P Varela; A Moreno; I Caragol; F García-Martín; J Guillén-Perales; T Olivé; T Español; A Arnaiz-Villena
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  CD48-deficient mice have a pronounced defect in CD4(+) T cell activation.

Authors:  J González-Cabrero; C J Wise; Y Latchman; G J Freeman; A H Sharpe; H Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

4.  Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions.

Authors:  H Kupfer; C R Monks; A Kupfer
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

5.  Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.

Authors:  J Stöckl; O Majdic; P Kohl; W F Pickl; J E Menzel; W Knapp
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

6.  Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes.

Authors:  J Punnonen; B G Cocks; J M Carballido; B Bennett; D Peterson; G Aversa; J E de Vries
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

7.  CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.

Authors:  K Kato; M Koyanagi; H Okada; T Takanashi; Y W Wong; A F Williams; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.